Skip to main content

Table 1 The expression of LINC00261and its clinical character in multiple cancers

From: LINC00261: a burgeoning long noncoding RNA related to cancer

Cancer type

Property

Expression

Cases

Clinical character

Prognosis

PMID

Pancreatic cancer

Suppressor

⬇

229

Prognosis

Favorable

30,210,701

  

⬇

/

Prognosis

Favorable

32,414,223

  

⬇

40

Prognosis

Favorable

32,929,371

  

⬇

/

Prognosis

Favorable

33,122,827

Gastric cancer

Suppressor

⬇

/

Prognosis

Favorable

27,439,973

  

⬇

/

Prognosis

Favorable

27,878,953

 Colon cancer

Suppressor

⬇

138

Prognosis

Favorable

31,850,713

Lung cancer

Suppressor

⬇

150

Prognosis

Favorable

29,272,004

  

⬇

52

Prognosis

Favorable

31,190,356

  

⬇

78

Prognosis

Favorable

32,607,060

  

⬇

881

Prognosis

Favorable

32,181,394

Hepatocellular carcinoma

Suppressor

⬇

45

Prognosis

Favorable

29,278,875

  

⬇

317

Prognosis

Favorable

29,761,859

  

⬇

44

Prognosis

Favorable

33,520,374

  

⬇

74

Prognosis

Favorable

30,377,132

Breast cancer stem cells

Suppressor

⬇

103

Prognosis

Favorable

33,274,565

Laryngeal carcinoma

Suppressor

⬇

66

Prognosis

Favorable

29,774,690

Prostate cancer

Suppressor

⬇

83

Prognosis

Favorable

33,013,201

Choriocarcinoma

Suppressor

⬇

60

Prognosis

Favorable

27,983,929

Cholangiocarcinoma

Oncogene

⬆

50

Prognosis

Poor

31,812,439